Literature DB >> 2891104

An anonymous single-copy clone, pC63, from chromosome 17q23-qter identifies a frequent RFLP [HGM9 No. D17S21].

S Kondoleon1, P van Tuinen, D H Ledbetter, H Vissing, M Litt.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2891104      PMCID： PMC306442          DOI： 10.1093/nar/15.21.9096

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  1 in total

1.  Progress towards construction of a total restriction fragment map of a human chromosome.

Authors:  H Vissing; F Grosveld; E Solomon; G Moore; N Lench; N Shennan; R Williamson
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971
  1 in total
  5 in total

1.  X rays induce interallelic homologous recombination at the human thymidine kinase gene.

Authors:  M B Benjamin; J B Little
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  A system for assaying homologous recombination at the endogenous human thymidine kinase gene.

Authors:  M B Benjamin; H Potter; D W Yandell; J B Little
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

3.  Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction.

Authors:  M A Peinado; S Malkhosyan; A Velazquez; M Perucho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 4.  Xp-duplications with and without sex reversal.

Authors:  A Baumstark; G Barbi; M Djalali; C Geerkens; B Mitulla; T Mattfeldt; J C de Almeida; F R Vargas; J C Llerena Júnior; W Vogel; W Just
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

5.  Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region.

Authors:  B Leggett; J Young; R Buttenshaw; L Thomas; B Young; G Chenevix-Trench; J Searle; M Ward
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.